Many questions need to be discussed before 3D‐mammography is adopted for standard screening
In this issue of the MJA, Houssami and colleagues report the first prospective trial of breast tomosynthesis screening in the Australian BreastScreen program. They found that tomosynthesis has a higher cancer detection rate (CDR) than standard mammography; the trade‐offs were a higher recall rate, higher radiation dose, and longer reading time.1
Publication of your online response is subject to the Medical Journal of Australia's editorial discretion. You will be notified by email within five working days should your response be accepted.